Platform technology management of biotechnology companies in Japan.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 3, p. 39, doi. 10.5912/jcb1016
- By:
- Publication type:
- Article
Works matching IS 14628732 AND DT 2021 AND VI 26 AND IP 3
Results: 7
1
2
Using Lean Startup to Discover Customers in the mHealth Industry: Current Landscape and Challenges.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 3, p. 25, doi. 10.5912/jcb1015
- By:
- Publication type:
- Article
3
A Systematic Review of Bio entrepreneurship Education.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 3, p. 9, doi. 10.5912/jcb1014
- By:
- Publication type:
- Article
4
Vaccine Hesitancy: When Political Miscommunication Replaces Scientific Benefit/Risk Assessment.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 3, p. 3, doi. 10.5912/jcb1012
- By:
- Publication type:
- Article
5
Value over Volume: Maximizing Resources by Prioritizing Value: The Dubai Healthcare Experience.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 3, p. 5, doi. 10.5912/jcb1013
- By:
- Publication type:
- Article
6
Consensus on Metrics for the Assessment of a Medical Science Liaison Using the Delphi Method.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 3, p. 37, doi. 10.5912/jcb982
- By:
- Publication type:
- Article
7
Innovations arising from post-COVID-19 in Bio entrepreneurship Education.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 3, p. 21, doi. 10.5912/jcb1014
- By:
- Publication type:
- Article